Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fielding

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Blood|September 11, 2019
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stressRichard Burt, Aditi Dey, Sarah Aref, et al.
Blood|March 9, 2017
Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Michael Magnussen, Theresa E León, et al.
Blood Advances|March 3, 2023
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemiaDaniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, et al.
The Lancet. Oncology|December 20, 2014
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S Topp, Nicola Gökbuget, Anthony S Stein, et al.
Blood|September 24, 2024
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Gianna Bloye, Nadine Farah, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Blood|September 11, 2019
Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stressRichard Burt, Aditi Dey, Sarah Aref, et al.
Blood|March 9, 2017
Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Michael Magnussen, Theresa E León, et al.
Blood Advances|March 3, 2023
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemiaDaniel Leongamornlert, Jesús Gutiérrez-Abril, SooWah Lee, et al.
The Lancet. Oncology|December 20, 2014
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 studyMax S Topp, Nicola Gökbuget, Anthony S Stein, et al.
Blood|September 24, 2024
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemiaSunniyat Rahman, Gianna Bloye, Nadine Farah, et al.
The New England Journal of Medicine|March 2, 2017
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic LeukemiaHagop Kantarjian, Anthony Stein, Nicola Gökbuget, et al.
The Lancet. Haematology|March 31, 2022
Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trialDavid I Marks, Amy A Kirkwood, Clare J Rowntree, et al.
Cancer Discovery|November 9, 2022
Human Bone Marrow Organoids for Disease Modeling, Discovery, and Validation of Therapeutic Targets in Hematologic MalignanciesAbdullah O Khan, Antonio Rodriguez-Romera, Jasmeet S Reyat, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Leukemia|December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008M Brüggemann, A Schrauder, T Raff, et al.
Pageof 17